Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Protein Interactions
Biotech
Insilico puts undruggable cancer targets in its crosshairs
After disclosing a series of alliances over the summer, Insilico has now taken the lid off a new partnership focused on undruggable cancer targets.
Nick Paul Taylor
Sep 8, 2021 8:40am
Lumicks snags $93M for its molecular tweezers, CAR-T hardware
Apr 19, 2021 9:45am
Chan Zuckerberg awards $68M for cell-mapping seed projects
Jun 26, 2019 9:25am
Protein analysis uncovers new treatment targets for colon cancer
Apr 29, 2019 11:25am
Adding a 'switch' to Cas9 to make CRISPR safer
Jan 11, 2019 9:56am
Merck taps Cyclica for AI screening of protein-drug interactions
Dec 7, 2018 4:15pm
